Cabaletta Market Capitalization from 2010 to 2025
| CABA Stock | USD 1.61 0.04 2.55% |
Check Cabaletta Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cabaletta Bio's main balance sheet or income statement drivers, such as Interest Expense of 1.4 M, Selling General Administrative of 23.2 M or Research Development of 66.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0241 or PTB Ratio of 3.72. Cabaletta financial statements analysis is a perfect complement when working with Cabaletta Bio Valuation or Volatility modules.
Cabaletta | Market Capitalization |
Latest Cabaletta Bio's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Cabaletta Bio over the last few years. It is Cabaletta Bio's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cabaletta Bio's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 78.69 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Cabaletta Market Capitalization Regression Statistics
| Arithmetic Mean | 304,510,102 | |
| Geometric Mean | 294,623,267 | |
| Coefficient Of Variation | 20.08 | |
| Mean Deviation | 40,009,618 | |
| Median | 335,755,287 | |
| Standard Deviation | 61,138,437 | |
| Sample Variance | 3737.9T | |
| Range | 238.2M | |
| R-Value | (0.51) | |
| Mean Square Error | 2972.5T | |
| R-Squared | 0.26 | |
| Significance | 0.04 | |
| Slope | (6,519,934) | |
| Total Sum of Squares | 56068.6T |
Cabaletta Market Capitalization History
About Cabaletta Bio Financial Statements
Cabaletta Bio stakeholders use historical fundamental indicators, such as Cabaletta Bio's Market Capitalization, to determine how well the company is positioned to perform in the future. Although Cabaletta Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cabaletta Bio's assets and liabilities are reflected in the revenues and expenses on Cabaletta Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cabaletta Bio. Please read more on our technical analysis and fundamental analysis pages.
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania. Cabaletta Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 57 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of Cabaletta Bio Correlation against competitors. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.